Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14Gastrointestinal 13Gynecologic 7Thoracic 5Head & Neck 5Dermatologic 5Tumor-Agnostic 3CNS 3Sarcoma 2Genitourinary 2Other solid neoplasm 1

Conditions

Pediatric Patients With Solid Tumors 1

Interventions

Cisplatin 81Gemcitabine 58Carboplatin 57Irinotecan 56Paclitaxel 53Pemetrexed 47Docetaxel 39Nivolumab 33Fluorouracil 30Bevacizumab 27pembrolizumab 25Cyclophosphamide 24Capecitabine 24Oxaliplatin 22Leucovorin 21Topotecan 19durvalumab 17Erlotinib Hydrochloride 17Sorafenib 16Everolimus 16Etoposide 16Bortezomib 16Ipilimumab 15Injections 15Sunitinib 14Filgrastim 14Early Intervention, Educational 14atezolizumab 13alvocidib 13Sirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Indocyanine Green × Other solid neoplasm × Clear all
NCT02910726 2022-10-05

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

Memorial Sloan Kettering Cancer Center

Phase 2/3 Completed
6 enrolled 4 charts
Other solid neoplasm

Pediatric Patients With Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡